The Research and Development Team at Amylin Pharmaceuticals is dedicated to advancing innovative therapies for diabetes through rigorous scientific investigation and collaboration. Comprising experts in medical science, research, and clinical surveillance, the team focuses on the discovery and refinement of diagnostic and therapeutic products, ensuring they are safe and effective for patients. Their commitment to challenging conventional science drives the development of groundbreaking solutions that aim to improve the lives of those living with diabetes.
View all